Knight Therapeutics reports Q3 results
Source: SeekingAlpha
2025-11-06 08:25:56 ET
More on Knight Therapeutics Inc.
- Seeking Alpha’s Quant Rating on Knight Therapeutics Inc.
- Historical earnings data for Knight Therapeutics Inc.
- Financial information for Knight Therapeutics Inc.
Read the full article on Seeking Alpha
For further details see:
Knight Therapeutics reports Q3 results
Knight Therapeutics Inc
NASDAQ: KHTRF
KHTRF Trading
0.0% G/L:
$4.6135 Last:
100 Volume:
$4.6135 Open:
KHTRF Latest News
February 18, 2026 07:30:00 am
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil
December 18, 2025 07:30:00 am
Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris
KHTRF Stock Data
$437,402,706
64,937,563
0.03%
86
N/A
Pharmaceuticals
Healthcare
CA
Saint- Laurent
